Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-002545
Filing Date
2025-01-31
Accepted
2025-01-31 18:03:33
Documents
2
Period of Report
2025-01-29

Document Format Files

Seq Description Document Type Size
1 form3-01312025_110129.html 3  
1 form3-01312025_110129.xml 3 1640
2 ex24-01312025_110129.htm EX-24 5809
  Complete submission text file 0001415889-25-002545.txt   9010
Mailing Address C/O AYALA PHARMACEUTICALS, INC. OPPENHEIMER 4 REHOVOT L3 7670104
Business Address
Gordon Gary B. (Reporting) CIK: 0001811354 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39813 | Film No.: 25579747

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)